NeuroBo Pharmaceuticals | Investor Presentation Deck | 27 slides · page 24 of 27
Explains the 505(b)(2) pathway and associated market exclusivity.
Pitch deck · appendix · appendix · dense density
Slide locked Sign in to view
Slide schematic 5/5
list 4/4 title 1/1
Components 5
bullet bullet bullet bullet headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.